Ozonated Gel Phonophoresis On Chronic Lateral Epicondylitis

Cairo University40 enrolled

Overview

Comparison between 2 groups of chronic lateral epicondylitis, to determine the effect of ozonated media phonophoresis on chronic lateral epicondylitis.

40 patients (male and female), patients age would be ranged from 30 to 50 years, would be randomly allocated using sealed envelope into randomly two matched group (A and B), Group A (Experimental): 20 patients would receive ultrasonic with ozonated gel as a coupling medium (phonophoresis) (1 MHz, 1 W/cm2continuous mode) for 5 min. plus, conventional physical therapy program consists of (conventional TENS (100 Hz) for 30 min - hot pack for 20 min- stretching and strengthening exercises, wrist rest splints). 3 times per week for 4 weeks. Group B (control):20 patients will receive conventional physical therapy program consists of (conventional TENS (100 Hz) for 30 min - hot pack for 20 min- stretching and strengthening exercises, wrist rest splints) 3times per week for 4 weeks.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Epicondylitis

Interventions

phonophoresisDEVICE

1 MHz, 1 W/cm2continuous mode of ultrasound therapy for 5 min. using ozonated gel as a coupling medium

conventional physical therapyOTHER

conventional TENS (100 Hz) for 30 min - hot pack for 20 min- stretching and strengthening exercises, wrist rest splints 3times per week for 4 weeks.

Eligibility

Sex: ALLMin age: 30 YearsMax age: 50 Years

Medical Language ↔ Plain English

Inclusion Criteria: * All patients would be diagnosed as chronic lateral epicondylitis from both genders. * Patients with chronic lateral epicondylitis that diagnosed by orthopedist. * Positive clinical manifestation in all patients. * Pain onset is more than 3 months. * All participants must be medically stable and not be treated with analgesics or any medication which may cause misleading results. * All patients had body mass index between 18.5 and 29.9 kg/m2. Exclusion Criteria: * Subjects would be excluded if they have: Received intra articular injection from duration less than 3 months. * Elbow instability. * History of cancer. * Pregnancy * Infection. * Skin diseases on elbow area. * Open wound in elbow. * Shoulder or elbow fractures * Systemic diseases such as rheumatoid arthritis, Reiter's syndrome, or diabetes. * Neurological diseases. * Severe medical or psychiatric disorders. * Elbow surgery. * Entrapment of the radial nerve. * Arthritis and effusion of the elbow.

Outcomes

Primary Outcomes

Pain status

assessment of pain using (visual analogue scale)s a horizontal line, 100 mm in length, anchored by word descriptors at each end. 2) The patient mark millimeters ed on the line the point that they feel ed represents their perception of their current state. The VAS score is determined by measuring in from the start point of the line to the point that the patient marks It was used to evaluate pain intensity. The VAS is a self. reported pain meas urement scale. The extremes of the line are labelled as no pain and worst pain. Each subject was asked to mark the point on the line that exactly corresponded to his/her pain .

Time frame: 4 weeks

wrist ROM

Measurment of wrist range of motion using universal goniometer

Time frame: 4 weeks

Hand grip strength

measurment of hand grip strength using hand grip dynamometer

Time frame: 4 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.